Canadian study suggests MRI scans prior to starting active surveillance in prostate cancer patients
Failure to fully recognize the amount of disease at baseline may be cause for active surveillance (AS) failure, according to new data from researchers at the Princess Margaret Hospital in Toronto. They reported at the American Urological Association (AUA) 2011 Annual Meeting that magnetic resonance imaging (MRI) discovered large volume disease in up to 22% of patients with low-risk prostate cancer who were managed with AS